The U. S. is seeing a big change in how obesity is treated. Novo Nordisk has just launched the first-ever GLP-1 pill for weight loss. This pill, called Wegovy, is a game-changer because it's much cheaper than the usual weekly injections. The price ranges from $149 to $299 per month, depending on the
Obesity in young people is a pressing issue. It's not just about looks. It can lead to serious health problems. Doctors often prescribe medications to help. But these meds can have side effects. They might cause poor nutrition. This is a big problem. Young people may not stick to their treatment pla
The body has a clever way of keeping weight within a certain range. It does this by using hormones to control hunger and energy use. When someone eats less, the body fights back. It slows down metabolism and makes a person feel hungrier. This is why losing weight and keeping it off is so tough. Obe
Two major drug companies, Lilly and Novo Nordisk, are close to striking a deal with the White House. They want to offer their weight loss drugs at a lower price. This is big news because it could mean more people can afford these medicines. The plan is to sell the lowest dose of their obesity drugs
By 2035, more than half of the planet's people might be overweight or obese. That's a big problem, but there's hope. Exercise, especially high-intensity interval training (HIIT), can help manage weight and improve health. But what if we could give workouts a little extra oomph? Enter therapeutic ul
Obesity is a big problem worldwide. It's not just about looking a certain way. It can lead to serious health issues, like type 2 diabetes. Many people try to change their lifestyle to manage their weight. But sometimes, that's not enough. That's where new medicines come in. Scientists have created
People who are overweight or obese often try different treatments to manage their weight. One such treatment involves medicines that mimic natural hormones in the body. These hormones, like GLP-1 and GIP, help control blood sugar and appetite. A recent study looked at how these medicines affect tas
The battle against severe obesity continues to be a tough one. Many strategies have been tried, but long-term success remains elusive. Orlistat and metformin are two drugs that have been in the spotlight for their potential to help. But how effective are they really? Let's dive in and see what th
The battle against obesity is a tough one, especially when it comes to keeping the weight off. Continuous care, where experts regularly guide patients, seems to help. But, it's expensive and hard to keep up. So, finding new ways to support people in maintaining their weight loss is crucial. In the
A recent study pitted two popular weight loss drugs against each other. The results showed that Zepbound, made by Eli Lilly, helped people shed nearly 50% more weight than those using Wegovy, from Novo Nordisk. This was the first time these two blockbuster medications faced off in a clinical trial.
